Afya Ltd AFYA posted 6 revenue growth with adjusted EBITDA margin up 100 basis points to 44 , while continuing education and medical practice solutions lagged.
Afya Limited Class A (AFYA) — Live Session & Technical Brief
Updated Nov 17, 2026 2:26 PM ET · Prev Close $10.09
Session Regime & Catalyst Assessment
64% Signal ConvictionControlled Session Consolidation (+0.89%) in Education & Training Services
Afya Limited Class A (Afya) is trading within a tight intraday band at $10.18 (+0.89%, 0.16x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AFYA is outperforming the S&P 500 by +2.10%. 14-day RSI stands at 35.0, keeping momentum in a bearish regime.
Afya Ltd AFYA posted 6 revenue growth with adjusted EBITDA margin up 100 basis points to 44 , while continuing education and medical practice solutions lagged.
Price ($10.18) trades relative to 20-day SMA ($11.12) and 50-day SMA ($12.65).
Market & Sector Relative Strength
AFYA outperforming the S&P 500 by +2.10%Recent AFYA Catalyst Headlines
Verified WireIf you had looked at Afya on 1 January 2026, seen analysts arguing over whether it was worth more or less than the market price, and still decided to buy, the result would have stung. Holding Afya from the start of the y
Short-duration courses are pulling enrollment toward lower-tuition programs, so revenue per student matters as much as headcount.
Medical seat growth and tuition gains met margin pressure and a pending merger.
1–3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $11.12 (20-day SMA resistance) for directional breakout confirmation.
Technical Regime (AFYA)
BEARISH MA TRENDRetail & Crowd Sentiment
QuietStockTwits user, using Stock Meadow's scoring model, ranked $AFYA as the 12th best stock in the consumer defensive sector with a score of 84.
About Afya Limited Class A
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate …
Get Instant AFYA Catalyst Alerts
Receive an email alert when AFYA triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversAFYA Session & Catalyst FAQ
Why is AFYA stock trading near flat today?
Afya Limited Class A (Afya) is trading within a tight intraday band at $10.18 (+0.89%, 0.16x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AFYA is outperforming the S&P 500 by +2.10%. 14-day RSI stands at 35.0, keeping momentum in a bearish regime.
Is AFYA stock a buy or sell right now?
Today's session carries a 64% catalyst conviction score on 0.16x relative volume (low participation). Our multi-factor model currently rates AFYA as HOLD. Review full valuation, quality, and timing signals on the AFYA Buy or Sell Decision Brief →
What is AFYA's intrinsic value and expected trading range?
At $10.18, AFYA's modeled 1-to-3 session range is $9.87 – $10.49, with a key inflection level at $11.12 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the AFYA Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
What do RSI and moving averages signal for AFYA?
RSI at 35.0 reflects soft below-midline momentum. AFYA trades at $10.18 relative to its 20-day SMA ($11.12) and 50-day SMA ($12.65), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.